Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C43H53NO9.2Na |
Molecular Weight | 773.8618 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]4(COC(=O)\C=C\C3=C(NC(=O)\C=C\C([O-])=O)C=CC(O)=C3)C2=CC[C@]5([H])[C@@]6(C)CCC(=O)C(C)(C)[C@]6([H])CC[C@@]45C)C([O-])=O
InChI
InChIKey=IFRVJMXGQTZXKQ-HECZARPRSA-L
InChI=1S/C43H55NO9.2Na/c1-38(2)19-20-42(37(51)52)21-22-43(25-53-36(50)14-7-26-23-27(45)8-10-30(26)44-34(47)12-13-35(48)49)28(29(42)24-38)9-11-32-40(5)17-16-33(46)39(3,4)31(40)15-18-41(32,43)6;;/h7-10,12-14,23,29,31-32,45H,11,15-22,24-25H2,1-6H3,(H,44,47)(H,48,49)(H,51,52);;/q;2*+1/p-2/b13-12+,14-7+;;/t29-,31-,32+,40-,41+,42-,43-;;/m0../s1
Molecular Formula | C43H53NO9 |
Molecular Weight | 727.8822 |
Charge | -2 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:42:31 GMT 2023
by
admin
on
Sat Dec 16 09:42:31 GMT 2023
|
Record UNII |
CXQ71T7YTY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
54687463
Created by
admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
|
PRIMARY | |||
|
S-0139
Created by
admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
|
PRIMARY | Phase 1 Multicenter, Randomized, Double-Blind, Placebo Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Response of PE0139 Injection in Adult Subjects With Type 2 Diabetes Mellitus | ||
|
SB-737004
Created by
admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
|
PRIMARY | |||
|
300000042371
Created by
admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
|
PRIMARY | |||
|
162117-90-0
Created by
admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
|
PRIMARY | |||
|
CXQ71T7YTY
Created by
admin on Sat Dec 16 09:42:31 GMT 2023 , Edited by admin on Sat Dec 16 09:42:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|